The Research Administration leads, regulates, and develops the scientific research and clinical research and trials ecosystem at King Abdullah Medical City, and provides the institutional, scientific, and regulatory environment required to conduct high-quality, impactful research in accordance with approved scientific, ethical, and regulatory standards.

The Administration gives strategic priority to clinical research and trials by strengthening the Medical City’s readiness to attract and conduct high-quality, funded clinical studies, and by expanding collaboration with pharmaceutical, biotechnology, medical-device, research, academic, and healthcare organizations. This helps provide patients with access to modern treatments and technologies, develop research expertise, and strengthen the Medical City’s position as an attractive center for clinical research and trials.

The Administration also develops the clinical research economy and research investment by attracting funded studies and research partnerships, enhancing the financial and operational efficiency of studies, developing research revenues, and reinvesting them in research infrastructure, capabilities, and the sustainability of the research ecosystem.

Areas of Work

  • Clinical Research and Trials: Attracting, developing, and managing clinical studies and trials; supporting their implementation and follow-up in accordance with approved standards and practices; and strengthening research and investment partnerships with the public and private sectors.
  • Human Research Protection Office: Strengthening compliance with ethical principles, laws, and regulations governing scientific research; protecting participants’ rights, safety, and privacy; and supporting the highest standards of research integrity and governance.
  • Disease Registries and Research Data: Developing and managing disease registries and research data, while enhancing data quality and reliability to support the identification of research priorities, clinical and research studies, knowledge generation, and evidence-based healthcare decision-making and practice. Disease registries include specialized registries such as oncology, intensive care, and organ transplantation registries.
  • Biostatistics and Methodological Support: Providing biostatistical consultations and methodological support to researchers throughout the different stages of research, including study design, sample-size determination, development of data-collection tools, data analysis, and interpretation of results, thereby enhancing study quality, the reliability of research outputs.

Through this system, the Research Administration seeks to move scientific research from knowledge generation to impact by linking research priorities with clinical needs, strengthening clinical trials, partnerships, and research investments, and transforming research capabilities into sustainable scientific, health, and economic value that improves healthcare quality and reinforces King Abdullah Medical City’s position as a leading and attractive center for clinical research.